Abstract
This review sought to identify the available scientific evidence on risk factors associated with adverse reactions to antituberculosis drugs. We performed a systematic review of studies published in the 1965-2012 period and indexed in the MEDLINE and LILACS databases. A total of 1,389 articles were initially selected. After reading their abstracts, we selected 85 studies. Of those 85 studies, 16 were included in the review. Risk factors for adverse reactions to antituberculosis drugs included age > 60 years, treatment regimens, alcoholism, anemia, and HIV co-infection, as well as sodium, iron, and albumin deficiency. Protective factors against hepatic adverse effects of antituberculosis drugs included being male (combined OR = 0.38; 95% CI: 0.20-0.72) and showing a rapid/intermediate N-acetyltransferase 2 acetylator phenotype (combined OR = 0.41; 95% CI: 0.18-0.90). There is evidence to support the need for management of adverse reactions to antituberculosis drugs at public health care facilities.
References
Dec 1, 1989·The American Review of Respiratory Disease·UNKNOWN Hong Kong Chest Service/British Medical Research Council
Dec 1, 1987·Tubercle·P F BarnesS F Wong
Apr 15, 1995·BMJ : British Medical Journal·P MangtaniL C Rodrigues
Jan 1, 1997·Advances in Pharmacology·F P Guengerich
Sep 24, 1999·Transactions of the Royal Society of Tropical Medicine and Hygiene·P M KellyJ M Kaldor
Oct 3, 2002·American Journal of Respiratory and Critical Care Medicine·Surendra K SharmaNarinder K Mehra
Jul 18, 2006·Thorax·R A M BreenM C I Lipman
Oct 24, 2007·Tuberculosis·Hyun-Jung ChoSoo-Youn Lee
Mar 28, 2008·Bulletin of the World Health Organization·Niyi Awofeso
Jul 22, 2008·BMC Public Health·Chawin SirinakJay K Varma
Sep 18, 2008·Cadernos de saúde pública·Pedro Emmanuel Alvarenga Americano do Brasil, José Ueleres Braga
Jun 19, 2009·American Journal of Therapeutics·Parvaneh BaghaeiMohammadreza Masjedi
Mar 9, 2010·BMC Public Health·Xianqin AiSusan van den Hof
Nov 5, 2010·Current Drug Safety·Hossein KhaliliEbrahim Azizi
Oct 21, 2011·Memórias do Instituto Oswaldo Cruz·Raquel Lima de Figueiredo TeixeiraAdalberto Rezende Santos
Feb 22, 2012·Tuberculosis·Kazutaka NanashimaKazuhiro Tsukamoto
May 24, 2013·Revista Panamericana De Salud Pública = Pan American Journal of Public Health·Alexandre San Pedro, Rosely Magalhães de Oliveira
Citations
Nov 13, 2015·PloS One·Natasha ChidaShama Mohammed
Jul 28, 2016·Human & Experimental Toxicology·E ElmorsyW G Carter
Dec 10, 2017·European Journal of Clinical Pharmacology·Lina Zhou, Anamika Paul Rupa
Dec 27, 2019·PloS One·María B ArriagaEduardo M Netto
Mar 29, 2019·BMC Infectious Diseases·Mehari Woldemariam MeridMelaku Kindie Yenit
Aug 31, 2020·International Journal of Mycobacteriology·Madeeha LaghariZohra Bhatti
Nov 4, 2016·The American Journal of Case Reports·Martha Matos-TocascaBryan Valcarcel-Valdivia
Mar 12, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Carolina Miranda de Sousa LimaJocivânia Oliveira da Silva
Jun 2, 2020·Indian Dermatology Online Journal·Reena K SharmaMudita Gupta